If nausea is a significant concern, trying a different injection site before adjusting your dose is a reasonable first step
The decision must be individualised, considering weight trajectory, metabolic control, gastrointestinal tolerability, and nutritional status, with close monitoring by a bariatric multidisciplinary team
Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-weekly subcutaneous injection
People With Type 2 Diabetes Blood Sugar Control: Semaglutide is prescribed to individuals with type 2 diabetes to help manage their blood sugar levels
However, introduce fiber slowly to avoid worsening bloating or gas
moreover, as individual heterogeneity is very obvious, more data is needed to support it